TBT
AZN icon

Texas Bank & Trust’s AstraZeneca AZN Stock Holding History

Texas Bank & Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.77M Buy
+9,355
New +$1.76M 0.58% 42
2026
Q1 		– Sell
-9,534
Closed -$1.75M – 177
2025
Q4 		$1.75M Buy
9,534
+420
+5% +$73.7K 0.64% 36
2025
Q3 		$1.4M Buy
9,114
+395
+5% +$59.8K 0.53% 46
2025
Q2 		$1.22M Buy
8,719
+437
+5% +$61.2K 0.48% 54
2025
Q1 		$1.22M Buy
8,282
+271
+3% +$39.2K 0.52% 50
2024
Q4 		$1.05M Buy
+8,011
New +$1.12M 0.43% 66

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Texas Bank & Trust's AZN Position: Q2 2026 in Review

Texas Bank & Trust opened a new position in AstraZeneca (AZN) in Q2 2026: 9,355 shares worth $1.77M. The stake represents 0.58% of the portfolio and ranks #42 among its holdings. This is a return to the name: Texas Bank & Trust previously reported a position in AZN as recently as Q4 2025.

Texas Bank & Trust first reported a position in AZN in Q4 2024 and has held it in 6 quarters since. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Texas Bank & Trust held 9,355 shares of AstraZeneca worth $1.77M as of Q2 2026.
  • AstraZeneca was a new Texas Bank & Trust position in Q2 2026.
  • AstraZeneca made up 0.58% of Texas Bank & Trust's portfolio in Q2 2026, its #42 holding.
  • Texas Bank & Trust first reported a position in AstraZeneca in Q4 2024 and has held it in 6 quarters since.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Texas Bank & Trust's 13F filing for Q2 2026, filed 31 Jul 2026.